Skip to main content
Log in

Pregnancy After Cardiac Surgery

  • Invited Mini Review
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Heart disease is one of the common, indirect obstetric causes of maternal death. Management of these cases may challenge the entire team providing care to the mother and fetus. Advances in cardiac surgery has improved quality of life and level of functioning of cardiovascular system of patients with congenital or acquired heart disease. These diseases complicate 0.1–4 % pregnancies. Maternal complications in the form of thromboembolic, hemorrhagic episode and heart failure may occur. The fetus is in danger of effects of oral anticoagulation therapy and other medications given to the patient in order to support cardiovascular system, intrauterine growth restriction and danger of hypoxia. In recent era, we are facing more pregnant patients with previous history of surgical correction of congenital or rheumatic heart disease. In this review, we have attempted to draw a management protocol of such patients based on the available literature and various international guidelines. In pregnant women with mechanical heart valves, recent data support warfarin use throughout pregnancy, followed by a switch to heparin and planned induction of labor. However, the complexity of this situation demands a cafeteria approach where the patient herself can choose from the available options that are supported by evidence-based information. Preconception counseling, evaluation and antenatal high-risk management protocol with the help of cardiologist and cardiac surgeon improves maternal and neonatal outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AHA:

American Heart Association

ACCP:

American College of Chest Physicians

ESC:

European Society of Cardiology

INR:

International normalized ratio

LMWH:

Low molecular weight heparin

UFH:

Unfractionated heparin

OAC:

Oral anticoagulants

References

  1. Royal College of Obstetricians and Gynaecologists. Why mothers die 2000–2002—the sixth report of confidential enquiries into maternal deaths in the United Kingdom. London: RCOG press; 2004.

    Google Scholar 

  2. Plesinac S, Pilic I. Course and outcome of pregnancy after the heart surgery. In: Proceedings of the world medical conference Prague. September 2011.

  3. Srivastava AP, Modi P, Sahi S, et al. Anticoagulation for pregnant patients. Ann Card Anesth. 2007;10:95–107.

    Article  Google Scholar 

  4. Elkayam U, Bitar F. Valvular heart disease and pregnancy part II: prosthetic valves. J Am Coll Cardiol. 2005;46(3):403–10. doi:10.1016/j.jacc.2005.02.087.

    Article  PubMed  Google Scholar 

  5. European Society of Gynecology (ESG), Association for European Pediatrics Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147.

    Article  Google Scholar 

  6. Hirsh J, Dalen JE, Deykin D et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. In: Fourth ACCP consensus conference on antithrombotic therapy. Chest. 1995; 108(suppl):231S–246S.

  7. Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy clinical update. Circulation. 2003;107:1240–6.

    Article  PubMed  Google Scholar 

  8. Castellano JM, Narayan RL, Vaishnava P, et al. Anticoagulation during pregnancy in patients with a prosthetic heart valve. Nat Rev Cardiol. 2012;9:415–24. doi:10.1038/nrcardio.2012.69.

    Article  CAS  PubMed  Google Scholar 

  9. James A. Committee on practice bulletins—obstetrics. Thromboembolism Pregnancy Obstet Gynecol. 2011;118(3):718–29. doi:10.1097/AOG.0b013e3182310c4c.

    Article  Google Scholar 

  10. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:e57.

    Article  PubMed  Google Scholar 

  11. Starling LD. Fetal warfarin syndrome. BMJ Case Reports http://casereports.bmj.com/content/2012/bcr-2012-007344.

  12. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systemic review of the literature. Arch Intern Med. 2000;160:191–6.

    Article  CAS  PubMed  Google Scholar 

  13. Sorin C. Juverdeanu surgical termination of pregnancy for maternal cardiac disease: a safer option? TMJ. 2009;59(2):169–72.

    Google Scholar 

  14. Ray P, Murphy GJ. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth. 2004;93(3):428–39.

    Article  CAS  PubMed  Google Scholar 

  15. Gary M, Harrison J. Analysis of severe adverse events related to the use of mifepristone as an abortifacient. Ann Pharmacother. 2006;40(2):191–7.

    Article  CAS  PubMed  Google Scholar 

  16. Bonow RO, Carabello BA, Chatterjee K et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523–661.

    Article  PubMed  Google Scholar 

  17. Gopalakrishnan S, Narayanan S. Oral anticoagulants: current Indian scenario. In: Medicine update. The Association of Physicians of India; 2013. p. 410–3.

  18. Sibai BM. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol. 1984;150(7):831–5.

    Article  CAS  PubMed  Google Scholar 

  19. North RA, Hunt B, Gaasch WH et al. Management of pregnant women with prosthetic heart valves, 2015.

  20. Silversides CK. Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep. 2009;11:298–305.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anjali Vivek Kanhere.

Ethics declarations

Conflict of interest

The author has no conflict of interest.

Additional information

Anjali Vivek Kanhere, MBBS, MD, FICOG FAIMER Fellow (GSMC Mumbai 2011), is a Professor and Head of Department, Department of Obstetrics and Gynecology at Chirayu Medical College and Hospital, Bhopal. Vivek Madhav Kanhere, MBBS, MS, MCh (Cardiothoracic Surgery), is a Consultant and Assistant Professor in Department of Cardiothoracic Surgery at Chirayu Cardiac Center, Chirayu Medical College and Hospital, Bhopal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanhere, A.V., Kanhere, V.M. Pregnancy After Cardiac Surgery. J Obstet Gynecol India 66, 10–15 (2016). https://doi.org/10.1007/s13224-016-0841-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-016-0841-y

Keywords

Navigation